Markel Ebit Per Revenue vs Total Revenue Analysis

MKL Stock

USD 1,718 24.33 1.44%

Markel financial indicator trend analysis is infinitely more than just investigating Markel recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Markel is a good investment. Please check the relationship between Markel Ebit Per Revenue and its Total Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Markel. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

For more information on how to buy Markel Stock please use our How to buy in Markel Stock guide.

Ebit Per Revenue vs Total Revenue

Ebit Per Revenue vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Markel Ebit Per Revenue account and Total Revenue. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Markel's Ebit Per Revenue and Total Revenue is -0.16. Overlapping area represents the amount of variation of Ebit Per Revenue that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Markel, assuming nothing else is changed. The correlation between historical values of Markel's Ebit Per Revenue and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit Per Revenue of Markel are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Ebit Per Revenue i.e., Markel's Ebit Per Revenue and Total Revenue go up and down completely randomly.

Correlation Coefficient

-0.16

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Ebit Per Revenue

Total Revenue

Total revenue comprises all receipts Markel generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Markel's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Markel current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Markel. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

For more information on how to buy Markel Stock please use our How to buy in Markel Stock guide.At this time, Markel's Tax Provision is quite stable compared to the past year. Enterprise Value is expected to rise to about 15.4 B this year, although the value of Selling General Administrative will most likely fall to about 613.3 M.

	2021	2022	2023	2024 (projected)
Gross Profit	12.8B	11.6B	15.6B	16.4B
Total Revenue	12.9B	11.8B	15.8B	16.6B

Gross Profit Total Revenue

Markel fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Net Debt	Retained Earnings	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Property Plant And Equipment Net	Non Current Assets Total	Non Currrent Assets Other	Intangible Assets	Other Assets	Net Receivables	Total Current Assets	Cash	Cash And Short Term Investments	Short Term Investments	Other Current Liab	Total Current Liabilities	Other Liab	Accounts Payable	Long Term Debt	Good Will	Common Stock
Total Assets		0.85	0.95	-0.13	0.93	0.58	0.57	-0.7	0.88	0.88	0.65	-0.5	0.87	-0.16	0.95	0.45	0.91	0.64	0.49	-0.67	0.78	0.95	0.6	0.82	0.93	0.67
Short Long Term Debt Total	0.85		0.88	-0.26	0.78	0.74	0.35	-0.45	0.7	0.7	0.44	-0.44	0.79	-0.05	0.79	0.49	0.88	0.77	0.65	-0.71	0.54	0.83	0.64	0.82	0.82	0.78
Total Stockholder Equity	0.95	0.88		-0.22	0.95	0.61	0.61	-0.58	0.86	0.88	0.72	-0.48	0.88	-0.33	0.95	0.57	0.97	0.65	0.49	-0.63	0.79	0.96	0.55	0.83	0.95	0.7
Net Debt	-0.13	-0.26	-0.22		-0.26	0.09	-0.19	0.27	-0.06	-0.34	-0.21	0.0	-0.09	0.19	-0.21	-0.1	-0.45	-0.09	0.02	0.17	-0.26	-0.21	-0.04	-0.08	-0.2	-0.03
Retained Earnings	0.93	0.78	0.95	-0.26		0.38	0.68	-0.69	0.85	0.94	0.81	-0.43	0.87	-0.44	0.97	0.54	0.94	0.46	0.27	-0.6	0.88	0.91	0.49	0.75	0.95	0.49
Common Stock Shares Outstanding	0.58	0.74	0.61	0.09	0.38		-0.03	-0.01	0.46	0.25	0.06	-0.29	0.58	0.19	0.4	0.47	0.54	0.86	0.81	-0.65	0.07	0.55	0.58	0.75	0.5	0.92
Non Current Liabilities Total	0.57	0.35	0.61	-0.19	0.68	-0.03		-0.75	0.77	0.74	0.94	-0.64	0.38	-0.67	0.71	0.0	0.59	-0.13	-0.31	0.11	0.89	0.67	-0.27	0.17	0.51	0.09
Other Stockholder Equity	-0.7	-0.45	-0.58	0.27	-0.69	-0.01	-0.75		-0.66	-0.81	-0.64	0.69	-0.39	0.11	-0.74	0.21	-0.62	-0.07	0.09	0.16	-0.81	-0.68	-0.07	-0.32	-0.52	-0.14
Total Liab	0.88	0.7	0.86	-0.06	0.85	0.46	0.77	-0.66		0.81	0.84	-0.5	0.75	-0.45	0.89	0.38	0.8	0.39	0.23	-0.43	0.83	0.91	0.26	0.58	0.81	0.54
Property Plant And Equipment Net	0.88	0.7	0.88	-0.34	0.94	0.25	0.74	-0.81	0.81		0.79	-0.44	0.72	-0.37	0.93	0.32	0.89	0.35	0.16	-0.47	0.88	0.87	0.35	0.63	0.84	0.36
Non Current Assets Total	0.65	0.44	0.72	-0.21	0.81	0.06	0.94	-0.64	0.84	0.79		-0.47	0.58	-0.8	0.8	0.32	0.7	-0.01	-0.19	-0.09	0.92	0.74	-0.07	0.34	0.69	0.18
Non Currrent Assets Other	-0.5	-0.44	-0.48	0.0	-0.43	-0.29	-0.64	0.69	-0.5	-0.44	-0.47		-0.23	0.03	-0.51	0.3	-0.45	-0.15	-0.04	-0.03	-0.54	-0.56	0.1	-0.24	-0.29	-0.34
Intangible Assets	0.87	0.79	0.88	-0.09	0.87	0.58	0.38	-0.39	0.75	0.72	0.58	-0.23		-0.29	0.86	0.72	0.84	0.59	0.45	-0.75	0.64	0.8	0.71	0.85	0.95	0.62
Other Assets	-0.16	-0.05	-0.33	0.19	-0.44	0.19	-0.67	0.11	-0.45	-0.37	-0.8	0.03	-0.29		-0.37	-0.44	-0.32	0.29	0.42	-0.14	-0.58	-0.31	0.29	-0.03	-0.36	0.11
Net Receivables	0.95	0.79	0.95	-0.21	0.97	0.4	0.71	-0.74	0.89	0.93	0.8	-0.51	0.86	-0.37		0.45	0.93	0.48	0.31	-0.55	0.91	0.96	0.49	0.76	0.95	0.55
Total Current Assets	0.45	0.49	0.57	-0.1	0.54	0.47	0.0	0.21	0.38	0.32	0.32	0.3	0.72	-0.44	0.45		0.53	0.55	0.47	-0.68	0.25	0.44	0.64	0.68	0.69	0.51
Cash	0.91	0.88	0.97	-0.45	0.94	0.54	0.59	-0.62	0.8	0.89	0.7	-0.45	0.84	-0.32	0.93	0.53		0.63	0.45	-0.65	0.78	0.94	0.54	0.79	0.92	0.65
Cash And Short Term Investments	0.64	0.77	0.65	-0.09	0.46	0.86	-0.13	-0.07	0.39	0.35	-0.01	-0.15	0.59	0.29	0.48	0.55	0.63		0.96	-0.79	0.13	0.62	0.82	0.83	0.61	0.91
Short Term Investments	0.49	0.65	0.49	0.02	0.27	0.81	-0.31	0.09	0.23	0.16	-0.19	-0.04	0.45	0.42	0.31	0.47	0.45	0.96		-0.73	-0.06	0.46	0.79	0.68	0.45	0.82
Other Current Liab	-0.67	-0.71	-0.63	0.17	-0.6	-0.65	0.11	0.16	-0.43	-0.47	-0.09	-0.03	-0.75	-0.14	-0.55	-0.68	-0.65	-0.79	-0.73		-0.2	-0.57	-0.88	-0.8	-0.71	-0.64
Total Current Liabilities	0.78	0.54	0.79	-0.26	0.88	0.07	0.89	-0.81	0.83	0.88	0.92	-0.54	0.64	-0.58	0.91	0.25	0.78	0.13	-0.06	-0.2		0.84	0.14	0.47	0.78	0.26
Other Liab	0.95	0.83	0.96	-0.21	0.91	0.55	0.67	-0.68	0.91	0.87	0.74	-0.56	0.8	-0.31	0.96	0.44	0.94	0.62	0.46	-0.57	0.84		0.48	0.77	0.9	0.69
Accounts Payable	0.6	0.64	0.55	-0.04	0.49	0.58	-0.27	-0.07	0.26	0.35	-0.07	0.1	0.71	0.29	0.49	0.64	0.54	0.82	0.79	-0.88	0.14	0.48		0.83	0.68	0.64
Long Term Debt	0.82	0.82	0.83	-0.08	0.75	0.75	0.17	-0.32	0.58	0.63	0.34	-0.24	0.85	-0.03	0.76	0.68	0.79	0.83	0.68	-0.8	0.47	0.77	0.83		0.86	0.83
Good Will	0.93	0.82	0.95	-0.2	0.95	0.5	0.51	-0.52	0.81	0.84	0.69	-0.29	0.95	-0.36	0.95	0.69	0.92	0.61	0.45	-0.71	0.78	0.9	0.68	0.86		0.62
Common Stock	0.67	0.78	0.7	-0.03	0.49	0.92	0.09	-0.14	0.54	0.36	0.18	-0.34	0.62	0.11	0.55	0.51	0.65	0.91	0.82	-0.64	0.26	0.69	0.64	0.83	0.62

Click cells to compare fundamentals

Markel Account Relationship Matchups

Markel fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	37.5B	41.7B	48.5B	63.4B	55.0B	57.8B
Short Long Term Debt Total	3.6B	3.6B	4.4B	4.6B	3.8B	4.0B
Total Stockholder Equity	11.1B	12.8B	14.7B	13.1B	15.0B	15.7B
Net Debt	461.4M	(857.7M)	382.8M	(33.8M)	32.7M	31.1M
Retained Earnings	7.5B	8.2B	10.4B	9.8B	11.4B	11.9B
Common Stock Shares Outstanding	13.9M	13.8M	13.8M	13.6M	13.4M	9.9M
Liabilities And Stockholders Equity	48.7B	41.7B	63.6B	63.4B	55.0B	57.8B
Non Current Liabilities Total	3.5B	3.5B	4.4B	4.1B	39.5B	41.5B
Other Stockholder Equity	937.6M	592.3M	614.75	(13.1B)	(11.8B)	(11.2B)
Total Liab	19.4B	21.2B	24.2B	25.5B	39.5B	41.5B
Property Plant And Equipment Net	441.9M	1.2B	1.6B	1.7B	1.9B	2.0B
Non Current Assets Total	22.8B	24.1B	27.7B	4.4B	75.6B	79.4B
Non Currrent Assets Other	(22.8B)	(1.2B)	(1.7B)	(24.0B)	(30.7B)	(29.2B)
Intangible Assets	1.7B	1.8B	1.8B	1.7B	1.6B	1.7B
Other Assets	(6.9B)	(7.4B)	(7.3B)	56.1B	(30.8B)	(29.2B)
Net Receivables	7.3B	7.9B	9.7B	11.4B	12.7B	13.3B
Total Current Assets	21.5B	25.0B	28.1B	3.0B	10.2B	6.4B
Cash	3.1B	4.3B	4.0B	4.1B	4.3B	4.5B
Cash And Short Term Investments	14.2B	17.1B	18.4B	18.7B	10.2B	7.8B
Short Term Investments	11.2B	12.7B	14.4B	14.5B	3.8B	6.0B
Accumulated Other Comprehensive Income	208.8M	584.4M	237.6M	(857.1M)	(478.2M)	(454.3M)
Other Current Liab	(5.7B)	(6.2B)	(7.5B)	(8.7B)	(1.1B)	(1.0B)
Total Current Liabilities	5.7B	6.2B	7.5B	8.7B	15.5B	16.3B
Other Liab	17.9B	19.7B	22.3B	24.6B	28.3B	29.7B
Accounts Payable	5.7B	6.2B	7.5B	8.7B	1.0B	985.8M
Long Term Debt	3.5B	3.5B	4.4B	4.1B	3.8B	2.1B
Good Will	2.3B	2.6B	2.9B	2.6B	2.6B	2.8B
Common Stock	3.4B	3.4B	3.4B	3.5B	3.5B	2.2B
Property Plant Equipment	588.6M	632M	1.6B	1.7B	2.0B	2.1B
Other Current Assets	(303.1M)	9.6B	9.1B	(447K)	11.5B	12.1B
Short Term Debt	113.0M	126.8M	0.0	500.5M	202.0M	191.9M
Net Tangible Assets	7.2B	8.1B	9.0B	8.6B	9.9B	6.4B
Noncontrolling Interest In Consolidated Entity	7.5M	14.9M	22.9M	62.8M	72.2M	75.8M
Common Stock Total Equity	3.4B	3.4B	3.4B	3.5B	4.0B	3.1B
Retained Earnings Total Equity	7.5B	8.2B	10.4B	9.8B	11.3B	11.9B
Inventory	303.1M	(9.6B)	(9.1B)	(27.1B)	(22.9B)	(21.8B)
Long Term Investments	18.8B	19.7B	23.4B	22.2B	26.5B	18.1B
Non Current Liabilities Other	22.7B	25.2B	28.9B	32.0B	36.8B	19.4B
Warrants	177.6M	245.6M	461.4M	523.2M	601.6M	631.7M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Markel is a strong investment it is important to analyze Markel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Markel's future performance. For an informed investment choice regarding Markel Stock, refer to the following important reports:

How To Invest In Markel

Details

Is Markel Stock a good investment?

Details

What is Markel's Net Worth?

Details

Largest Property & Casualty Insurance Companies

View

Largest Insurance - Property & Casualty Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Markel. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

For more information on how to buy Markel Stock please use our How to buy in Markel Stock guide.

You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Is Property & Casualty Insurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Markel. If investors know Markel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Markel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

20.099

Earnings Share

216.7

Revenue Per Share

1.3 K

Quarterly Revenue Growth

0.366

Return On Assets

0.0462

The market value of Markel is measured differently than its book value, which is the value of Markel that is recorded on the company's balance sheet. Investors also form their own opinion of Markel's value that differs from its market value or its book value, called intrinsic value, which is Markel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Markel's market value can be influenced by many factors that don't directly affect Markel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Markel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Markel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Markel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Markel Ebit Per Revenue vs Total Revenue Analysis

Ebit Per Revenue vs Total Revenue

Ebit Per Revenue vs Total Revenue Correlation Analysis

Correlation Coefficient

Ebit Per Revenue

Total Revenue

Markel fundamental ratios Correlations

Markel Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Markel fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 0.97	Total Stockholder Equity
Net Receivables	+ 0.97	Retained Earnings
Other Liab	+ 0.96	Total Stockholder Equity
Other Liab	+ 0.96	Net Receivables
Short Term Investments	+ 0.96	Cash And Short Term Investments
Total Stockholder Equity	+ 0.95	Total Assets

Accounts Payable	- 0.88	Other Current Liab
Total Current Liabilities	- 0.81	Other Stockholder Equity
Property Plant And Equipment Net	- 0.81	Other Stockholder Equity
Long Term Debt	- 0.8	Other Current Liab
Other Assets	- 0.8	Non Current Assets Total
Other Current Liab	- 0.79	Cash And Short Term Investments